<DOC>
	<DOCNO>NCT00667602</DOCNO>
	<brief_summary>The primary immunogenicity objective ass compare immunogenicity one dose MenACWY one dose Menjugate give healthy toddler 12 month age measure percentage subject serum bactericidal titer direct N. meningitidis serogroup C â‰¥ 1:8 obtain serum bactericidal assay use human complement ( hSBA ) .</brief_summary>
	<brief_title>Safety Immunogenicity Evaluation After One Two Doses Novartis Meningococcal ACWY Conjugate Vaccine Healthy Infants Toddlers</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>infant 6 8 month old inclusive , born full term pregnancy previously receive three dos Prevenar Infanrixhexa vaccine least 30 day study entry previously receive meningococcal vaccine ; previous confirm suspected disease cause N. meningitidis , C. diphtheriae , C. tetani , Poliovirus , Hepatitis B , Hib , Pneumococcus B. pertussis ; household contact and/or intimate exposure individual laboratory confirm N. meningitidis ( serogroups A , C , W135 , Y ) , B. pertussis , Hib , C. diphtheriae , Polio , pneumococcal infection time since birth ; Subjects serious , acute chronic progressive disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>8 Months</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Meningococcal</keyword>
	<keyword>ACWY</keyword>
	<keyword>Conjugate Vaccine</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Toddlers</keyword>
	<keyword>Infants</keyword>
	<keyword>Concomitant Vaccination</keyword>
</DOC>